Scientech Research »

Eyepoint Pharmaceuticals shares owned by Scientech Research

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Scientech Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $134k 10k 12.89

More positions owned by Scientech Research

Applied Digital Corp Com New (APLD)
Wave Life Sciences SHS (WVE)
Echostar Corp Cl A (SATS)
Themes Etf Tr Leverage Shs 2x (CRCG)
Scholar Rock Hldg Corp (SRRK)
Miragen Therapeutics (VRDN)
Figma Class A Com Stk (FIG)
Century Aluminum Company (CENX)
Oklo Com Cl A (OKLO)
Coinbase Global Com Cl A (COIN)
Five Below (FIVE)
Cytomx Therapeutics (CTMX)
Graniteshares Etf Tr 2x Long Coin Dai (CONL)
Snowflake Com Shs (SNOW)
Planet Labs Pbc Com Cl A (PL)

View all positions for Scientech Research

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
Cormorant Asset Management
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
Adage Capital Partners GP
Henderson Group
Vanguard Capital Management
Paradigm Biocapital Advisors
Commodore Capital
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals